文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

根据最近德国前列腺癌 S3 指南,对接受开腹经耻骨后与腹腔镜或机器人辅助根治性前列腺切除术的患者进行盆腔淋巴结清扫的指南依从性进行多中心评估。

Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer.

机构信息

Department of Urology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.

Department of Urology, Caritas St. Josef Medical Center, University Regensburg, Landshuter Strasse 64, 93053, Regensburg, Germany.

出版信息

World J Urol. 2018 Jun;36(6):855-861. doi: 10.1007/s00345-018-2195-9. Epub 2018 Feb 9.


DOI:10.1007/s00345-018-2195-9
PMID:29427005
Abstract

PURPOSE: Pelvic lymph node dissection (PLND) is recommended for patients with prostate cancer (PCa) and significant risk for nodal metastases. This study aimed to assess guideline adherence regarding PLND according to the German S3 guideline as example for a national but highly used guideline on prostate cancer and to compare the rate of complications different approaches for radical prostatectomy (RP). METHODS: Patients undergoing open (RRP), laparoscopic (LARP) or robot-assisted (RARP) RP in six centers in Germany and Austria were included. The primary endpoint was the total number of removed lymph nodes (LN) between the different surgical approaches according to recent guideline recommendations. Secondary endpoints were the number of patients undergoing a sufficient PLND, defined as a removal of at least 10 LN and associated complication rates. RESULTS: 2634 patients undergoing RP were included (RRP: 66%, RARP/LARP: 34%). PLND was performed in 88% (RRP: 88.5%, RARP/LARP: 86.8%, p = 0.208). In intermediateor high risk PCa, PLND was performed in 97.2% (RRP: 97.7%, RARP/LARP: 96.2, p = 0.048). Of those, the mean number of LN was 19 (RRP: 19 vs. RARP/LARP: 17, p < 0.005) and sufficient PLND was observed in 84.6% of RRP compared to 77.2% of RARP/LARP (p < 0.005). Symptomatic lymphoceles requiring surgical treatment occurred more often in RRP than in RARP/LARP (4.0% vs. 1.6%, p = 0.001). CONCLUSIONS: The general guideline adherence regarding performing PNLD and the LN yield is high, regardless of the surgical approach. As expected, lymph node yield was higher when very experienced surgeons conducted the procedure. This should be considered in patients' counseling.

摘要

目的:盆腔淋巴结清扫术(PLND)推荐用于前列腺癌(PCa)患者和有淋巴结转移高风险的患者。本研究旨在评估德国 S3 指南中规定的 PLND 指南遵循情况,该指南是前列腺癌的国家指南,但应用非常广泛,并比较不同根治性前列腺切除术(RP)方法的并发症发生率。

方法:纳入德国和奥地利 6 个中心接受开放(RRP)、腹腔镜(LARP)或机器人辅助(RARP)RP 的患者。主要终点是根据最新指南建议,不同手术方法之间切除的淋巴结总数(LN)。次要终点是接受充分 PLND 的患者数量,定义为至少切除 10 个 LN,并评估相关并发症发生率。

结果:共纳入 2634 例接受 RP 的患者(RRP:66%,RARP/LARP:34%)。88%(RRP:88.5%,RARP/LARP:86.8%,p=0.208)的患者接受了 PLND。中高危 PCa 患者中,97.2%(RRP:97.7%,RARP/LARP:96.2%,p=0.048)接受了 PLND。其中,LN 的平均数量为 19(RRP:19 vs. RARP/LARP:17,p<0.005),RRP 中 84.6%的患者接受了充分的 PLND,而 RARP/LARP 中只有 77.2%(p<0.005)。需要手术治疗的症状性淋巴囊肿在 RRP 中比在 RARP/LARP 中更常见(4.0% vs. 1.6%,p=0.001)。

结论:无论手术方式如何,进行 PLND 和 LN 检测的总体指南遵循情况都很高。正如预期的那样,当经验非常丰富的外科医生进行手术时,淋巴结的检出量更高。这在患者咨询时需要考虑。

相似文献

[1]
Multicenter evaluation of guideline adherence for pelvic lymph node dissection in patients undergoing open retropubic vs. laparoscopic or robot assisted radical prostatectomy according to the recent German S3 guideline on prostate cancer.

World J Urol. 2018-2-9

[2]
Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.

Eur J Surg Oncol. 2015-11

[3]
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.

Eur Urol. 2013-4-6

[4]
Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis.

Int Urol Nephrol. 2019-2-22

[5]
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.

Eur Urol. 2014-1-4

[6]
The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.

Eur J Surg Oncol. 2014-9

[7]
The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience.

Can J Urol. 2009-10

[8]
Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.

BJU Int. 2012-11-13

[9]
Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era.

J Endourol. 2010-7

[10]
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.

Urol Oncol. 2018-2

引用本文的文献

[1]
The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review.

World J Surg Oncol. 2024-2-26

本文引用的文献

[1]
Extended versus Standard Pelvic Lymph Node Dissection in Radical Prostatectomy on Oncological and Functional Outcomes: A Systematic Review and Meta-Analysis.

Ann Surg Oncol. 2017-7

[2]
Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.

Minerva Urol Nefrol. 2017-2

[3]
Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy.

Can Urol Assoc J. 2016-8

[4]
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.

Eur Urol. 2016-8-31

[5]
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Eur Urol. 2016-8-25

[6]
Robots drive the German radical prostatectomy market: a total population analysis from 2006 to 2013.

Prostate Cancer Prostatic Dis. 2016-8-23

[7]
Prostate Cancer, Version 1.2016.

J Natl Compr Canc Netw. 2016-1

[8]
Best evidence regarding the superiority or inferiority of robot-assisted radical prostatectomy.

Urol Clin North Am. 2014-8-19

[9]
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.

Eur Urol. 2014-1-4

[10]
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.

Eur Urol. 2013-4-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索